Mosaic ImmunoEngineering Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Mosaic ImmunoEngineering Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2012 to Q4 2023.
  • Mosaic ImmunoEngineering Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $3.15M, a 11.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.15M +$324K +11.5% Dec 31, 2023 10-K 2024-04-15
Q4 2022 $2.83M +$709K +33.5% Dec 31, 2022 10-K 2024-04-15
Q4 2021 $2.12M +$1.09M +105% Dec 31, 2021 10-K 2023-03-02
Q4 2020 $1.03M Dec 31, 2020 10-K 2022-01-26
Q2 2020 $0 -$3.69M -100% May 31, 2020 10-KT 2021-03-02
Q2 2019 $3.69M $0 0% May 31, 2019 10-K 2019-08-29
Q2 2018 $3.69M May 31, 2018 10-K 2018-08-29
Q2 2013 -$15.6K +$10.2K +39.6% May 31, 2013 10-K 2013-08-23
Q2 2012 -$25.8K May 31, 2012 10-K 2013-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.